Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors

<div>Imaging of Posterior Thorax Desmoid Treatment Response. Coronal CT of a right paraspinal desmoid tumor before (a) and 12 months after (b) completing radiation therapy to 50 Gy in 25 fractions with concurrent imatinib demonstrating a significant reduction in tumor volume. The tumor is delineated with white brackets.</div>

Sarcoma

fig1

Figure 1

Figure 1: Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors 